Bispecific Humanized Anti-IL-2 Receptor αβ Antibodies Inhibitory for Both IL-2- and IL-15-Mediated Proliferation

Journal of Immunology

Volumn 159, Issue 3, 1997, Pages 1543-1556

  Pilson, Robert S ^a   Levin, Wayne ^a   Desai, Bhupesh ^a   Reik, Linda M ^a   Lin, Ping ^a   Korkmaz Duffy, Elcin ^a   Campbell, Elaine ^a   Tso, J Yun ^b   Kerwin, Jo A ^a   Hakimi, John ^a  

^a HOFFMANN LA ROCHE INC   (United States)

^b PROTEIN DESIGN LABS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPECIFIC ANTIBODY; BLOCKING ANTIBODY; DODECYL SULFATE SODIUM; GROWTH INHIBITOR; INTERLEUKIN 15; INTERLEUKIN 2 RECEPTOR;

ANTIBODY AFFINITY; ANTIBODY COMBINING SITE; ANTIBODY SPECIFICITY; ARTICLE; BIOSYNTHESIS; CELL CLONE; CELL CULTURE; CELL DIVISION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYBRID CELL; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; T CELL LEUKEMIA;

ANTIBODIES, BISPECIFIC; ANTIBODIES, BLOCKING; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; BINDING SITES, ANTIBODY; CELL DIVISION; CLONE CELLS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GROWTH INHIBITORS; HUMANS; HYBRID CELLS; INTERLEUKIN-15; LEUKEMIA, T-CELL; RECEPTORS, INTERLEUKIN-2; SODIUM DODECYL SULFATE; TUMOR CELLS, CULTURED;

EID: 0031201063     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Waldmann, T. A. 1989. The multi-subunit interleukin-2 receptor. Annu. Rev. Biochem. 58:875.
2. + cells. J. Immunol. 126:1393.
3. Leonard, W. J., J. M. Depper, T. Uchiyama, K. A. Smith, T. A. Waldmann, and W. C. Greene. 1982. A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor: partial characterization of the receptor. Nature 300:267.
4. Tsudo, M., R. W. Kozak, C. K. Goldman, and T. A. Waldmann. 1986. Demonstration of a non-Tac peptide that binds interleukin-2: a potential participant in a multichain interleukin-2 receptor complex. Proc. Natl. Acad. Sci. USA 83:9694.
5. Sharon, M., R. D. Klausner, B. R. Cullen, R. Chizzonite, and W. J. Leonard. 1986. Novel interleukin-2 receptor subunit detected by crosslinking under high-affinity conditions. Science 234:859.
6. Takeshita T., H. Asao, K. Ohtani, N. Ishii, S. Kumaki, N. Tanaka, H. Munakata, M. Nakamura, and K. Sugamura. 1992. Cloning of the γ chain of the human IL-2 receptor. Science 257:379.
7. Taniguchi, T., and Y. Minami. 1993. The IL-2/IL-2 receptor system: a current overview. Cell 73:5.
8. Nakamura, Y., S. M. Russell, S. A. Mess, M. Friedman, M. Erdos, C. Francois, Y. Jacques, S. Adelstein, and W. J. Leonard. 1994. Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domains is required for signalling. Nature 369:330.
9. Nelson, B. H., J. D. Lord, and P. D. Greenberg. 1994. Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation. Nature 369:333.
10. Ishii, N., T. Takeshita, Y. Kimura, K. Tada, M. Kondo, M. Nakamura, and K. Sugamura. 1994. Expression of the IL-2 receptor γ chain on various populations in human peripheral blood. Int. Immunol. 6:1273.
11. Nakarai, T., M. J. Robertson, M. Streuli, Z. Wu, T. L. Ciardelli, K. A. Smith, and J. Ritz. 1994. Interleukin 2 receptor γ chain expression on resting and activated lymphoid cells. J. Exp. Med. 180:241.
12. Grabstein, K. H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M. A. Schoenborn, M. Ahdieh, L. Johnson, M. R. Alderson, J. D. Watson, D. M. Anderson, and J. G. Giri. 1994. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965.
13. Bamford, R. N., A. J. Grant, J. D. Burton, C. Peters, G. Kurys, C. K. Goldman, J. Brenner, E. Roessler, and T. A. Waldmann. 1994. The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 91:4940.
14. Giri, J. G., M. Ahdieh, J. Eisenman, K. Shanebeck, K. Grabstein, S. Kumaki, A. Namen, L. S. Park, D. Cosman, and D. Anderson. 1994. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13:2822.
15. Carson, W. E., J. G. Giri, M. J. Lindemann, M. L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, and M. A. Caligiuri. 1994. Interleukin-(IL) 15 is an novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1395.
16. c receptor-ligand complex. J. Immunol. 156:1339.
17. Kondo, M., T. Takeshita, T. Ishii, N. Nakamura, S. Watanabe, K.-I. Arai, and K. Sugamura. 1993. Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science 262:1874.
18. Russell, S. M., A. D. Keegan, N. Harada, Y. Nakamura, M. Noguchi, P. Leland, M. C. Friedman, A. Miyajima, R. K. Puri, W. E. Paul, and W. J. Leonard. 1993. Interleukin-2 receptor γ chain: a functional component of the interleukin-4 receptor. Science 262:1880.
19. Noguchi, M., Y. Nakamura, S. M. Russell, S. F. Ziegler, M. Tsang, X. Cao, and W. J. Leonard. 1993. Interleukin-2 receptor γ chain: a functional component of the interieukin-7 receptor. Science 262:1877.
20. Kimura, Y., T. Takeshita, M. Kondo, N. Ishii, N. Nakamura, J. van-Snick, and K. Sugamura. 1995. Sharing of the IL-2 receptor γ chain with the functional IL-9 receptor complex. Int. Immunol. 7:115.
21. Giri, J. G., S. Kumaki, M. Ahdieh, D. J. Friend, A. Loomis, K. Shanebeck, R. DuBose, D. Cosman, L. S. Park, and D. M. Anderson. 1995. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor. EMBO J. 14:3654.
22. Anderson, D. M., S. Kumaki, M. Ahdieh, J. Bertles, M. Tometsko, A. Loomis, J. Giri, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, V. Valentine, D. N. Shapiro, S. W. Morris, L. S. Park, and D. Cosman. 1995. Functional characterization of the human interleukin-15 receptor α chain and close linkage of IL15RA and IL2RA genes. J. Biol. Chem. 270:29862.
23. Hakimi, J., V. C. Ha, P. Lin, E. Campbell, M. K. Gately, M. Tsudo, P. W. Payne, T. A. Waldmann, A. J. Grant, W.-H. Tsien, and W. P. Schneider. 1993. Humanized Mikβ1, a humanized antibody to the IL-2 receptor β-chain that acts synergistically with humanized anti-TAC. J. Immunol. 151:1075.
24. Tinubu, S. A., J. Hakimi, J. A. Kondas, P. Bailon, P. C. Familletti, C. Spence, M. D. Crittenden, G. L. Parenteau, F. M. Dirbas, M. Tsudo, J. D. Bacher, C. Kasten-Sportes, J. L. Martinucci, C. K. Goldman, R. E. Clark, and T. A. Waldmann. 1994. Humanized antibody directed to the IL-2 receptor β-chain prolongs primate cardiac allograft survival. J. Immunol. 153:4330.
25. Brown, P. S., Jr., B. L. Paranteau, F. M. Dirbas, R. J. Garsia, C. K. Goldman, M. A. Bukowski, R. P. Junghans, C. Queen, J. Hakimi, W. R. Benjamin, R. E. Clark, and T. A. Waldmann. 1991. Anti-Tac-H, a humanized antibody to the interleukin-2 receptor, prolongs primate cardiac allograft survival. Proc. Natl. Acad. Sci. USA 88:2663.
26. Vincenti, F., M. Lantz, J. Birnbaum, M. Garovoy, D. Mould, J. Hakimi, K. Nieforth, and S. Light. 1997. A Phase I trial of humanized anti-interleukin-2 receptor antibody (HAT) in renal transplantation. Transplantation 63:33.
27. Anasetti, C., J. A. Hanson, T. A. Waldmann, F. R. Appelbaum, J. Davis, H. J. Deeg, K. Doney, P. J. Martin, R. Nash, R. Storb, K. M. Sullivan, R. P. Witherspoon, M.-H. Binger, R. Chizzonite, J. Hakimi, D. Mould, H. Satoh, and S. E. Light. 1994. Treatment of acute graft-versus-host-disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor. Blood 84:1320.
28. Audrain, M., F. Boefard, J. P. Soullilou, and Y. Jacques. 1991. Synergistic action of monoclonal antibodies directed at p55 and p75 of the human IL-2 receptor. J. Immunol. 146:884.
29. Guex-Crosier, Y., J. Raber, C. Chan, M. S. Kriete, J. Benichou, R. S. Pilson, J. A. Kerwin, T. A. Waldmann, J. Hakimi, and F. G. Roberge. 1997. Humanized antibodies against the α-chain of the IL-2 receptor and against the β-chain shared by the IL-2 and IL-15 receptors in a monkey uveitis model of autoimmune diseases. J. Immunol. 158:452.
30. Milstein, C., and A. C. Cuello. 1983. Hybrid hybridomas and their use in immunohistochemistry. Nature 305:537.
31. Milstein, C., and A. C. Cuello. 1984. Hybrid hybridomas and the production of bi-specific monoclonal antibodies. Immunol. Today 5:299.
32. Jung, G., C. J. Honsik, R. A. Reisfeld, and H. J. Muller-Eberhard. 1986. Activation of human peripheral blood mononuclear cells by anti-T3: killing of tumor target cells coated with anti-target-anti-T3 conjugates. Proc. Natl. Acad. Sci. USA 83:4479.
33. Weiner, G. J., and J. R. Hillstrom. 1991. Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma. J. Immunol. 147:4035.
34. van Ravenswaay Clausen, H. H., R. J. van DeGriend, D. Mezzanzanica, R. L. H. Bolhuis, S. O. Warnaar, and G. J. Fleuren. 1993. Analysis of production, purification, and cytolytic potential of bi-specific antibodies reactive with ovarian-carcinoma-associated antigens and the T cell antigen CD3. Int. J. Cancer 55:128.
35. Renner, C., W. Jung, U. Sahin, R. Denfeld, C. Pohl, L. Trumper, F. Hartmann, V. Diehl, R. van Lier, and M. Pfreundschuh. 1994. Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells. Science 264:833.
36. Gruber, M., B. A. Schodin, E. R. Wilson, and D. M. Kranz. 1994. Efficient tumor cell lysis mediated by a bispecific singly chain antibody expressed in Escherichia coli. J. Immunol. 152:5368.
37. 2 bifunctional antibody activates and retargets tumor-infiltrating lymphocytes. J. Immunol. 155:1296.
38. MacLean, J. A., Z. Su, Y. Guo, M.-S. Sy, R. B. Colvin, and J. T. Wong. 1993. Anti-CD3:anti-IL-2 receptor bispecific monoclonal antibody: targeting of activated T cells in vitro. J. Immunol. 150:1619.
39. MacLean, J. A., Z. Su, R. B. Colvin, and J. T. Wong. 1995. Anti-CD3:anti-IL-2 receptor-bispecific mAb-mediated immunomodulation: low systemic toxicity, differential effect of lymphoid tissue, and inhibition of cell-mediated hypersensitivity. J. Immunol. 155:3674.
40. Kostelny, S. A., M. S. Cole, and J. Y. Tso. 1992. Formation of a bispecific antibody by the use of leucine zippers. J. Immunol. 148:1547.
41. Francois, C., F. Boeffard, B. Kaluza, U. H. Weidle, and Y. Jacques. 1993. Construction of a bispecific antibody reacting with the α- and β-chains of the human IL-2 receptor. High affinity cross-linking and high anti-proliferative efficiency. J. Immunol. 150:4610.
42. 2 targeted to the human IL-2 receptor. J. Hematother. 4:389.
43. Hakimi, J., R. Chizzonite, D. R. Luke, P. C. Familletti, P. Bailon, J. A. Kondas, R. S. Pilson, P. Lin, D. V. Weber, C. Spence, L. J. Mondini, W.-H. Tsien, J. L. Levin, V. H. Gallati, L. Korn, T. A. Waldmann, C. Queen, and W. R. Benjamin. 1991. Reduced immunogenicity and improved pharmacokinetics of humanized anti-tac in cynomolgus monkeys. J. Immunol. 147:1352.
44. Bailon, P., D. V. Weber, R. F. Keeney, J. E. Fredericks, C. Smith, P. C. Familletti, and J. E. Smart. 1987. Receptor-affinity chromatography: a one-step purification for recombinant interleukin-2. Biotechnology 5:1195.
45. Queen, C., W. P. Schneider, H. E. Selick, P. W. Payne, N. Landolfi, J. F. Duncan, N. M. Avdalovic, M. Levitt, R. P. Junghans, and T. A. Waldmann. 1989. A humanized antibody that binds to the interleukin-2 receptor. Proc. Natl. Acad. Sci. USA 86:10029.
46. Bebbington, C. R., G. Renner, S. Thomson, D. King, D. Abrams, and G. T. Yarranton. 1992. High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Biotechnology 10:169.
47. Kitamura, T., T. Tange, T. Terasawa, S. Chiba, T. Kuwaki, K. Miyagawa, Y.-F. Piao, K. Miyazono, A. Urabe, and F. Takaku. 1989. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol. 140:323.
48. c detection and function in YT lymphoid cells and in the granulocyte-macrophage colony-stimulating factor-responsive human myeloid cell line TF-1. Blood 86:4568.
49. Hori, T., T. Uchiyama, M. Tsudo, H. Umadome, H. Ohno, S. Fukuhara, K. Kita, and H. Uchino. 1987. Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus. Blood 70:1069.
50. Fazekas de St. Groth, S., and D. Scheidegger. 1980. Production of monoclonal antibodies: strategy and tactics. J. Immunol. Methods 35:1.
51. O'Shannessy, D. J., and M. Wilchek. 1990. Immobilization of glycoconjugates by their oligosaccharides: use of hydrazido-derivatized matrices. Anal. Biochem. 191:1.
52. Kamio, M., T. Uchiyama, N. Arima, K. Itoh, T. Ishikawa, T. Hori, and H. Uchino. 1990. Role of α chain-IL-2 complex in the formation of the ternary complex of IL-2 and high-affinity IL-2 receptor. Int. Immunol. 2:520.
53. Grant, A. J., E. Roessler, G. Ju, M. Tsudo, K. Sugamura, and T. A. Waldmann. 1992. The interleukin 2 receptor (IL-2R): the IL-2R α subunit alters the function of the IL-2Rβ subunit to enhance IL-2 binding and signaling by mechanisms that do not require binding of IL-2 to IL-2R α subunit. Proc. Natl. Acad. Sci. USA 89:2165.
54. Francois, C., M. Sorel, M. Cherel, H. Brailly, S. Minvielle, D. Blanchard, and Y. Jacques. 1995. Immunological characterization of antigenic domains on human IL-2 receptor β subunit: epitope-function relationships. Int. Immunol. 7:1173.
55. Kondo, S., F. Shimizu, T. Saito, M. Konoshita, and T. Honjo. 1986. Molecular basis for two different affinity states of the interleukin-2 receptor: affinity conversion model. Proc. Natl. Acad. Sci. USA 83:9026.
56. Saito, Y., H. Sabe, N. Suzuki, S. Kondo, T. Ogura, A. Shimizu, and T. Honjo. 1988. A large number of L chains (Tac) enhance the association rate of interleukin-2 to the high affinity site of the interleukin-2 receptor. J. Exp. Med. 168: 1563.
57. Doherty, T. M., R. A. Seder, and A. Sher. 1996. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 156:735.
58. Nishimura, H., K. Hiromatsu, N. Kobayashi, K. H. Grabstein, R. Paxton, K. Sugamura, J. A. Bluestone, and Y. Yoshikai. 1996. IL-15 is a novel growth factor for murine gamma-delta T cells induced by Salmonella infection. J. Immunol. 156:663.
59. Kumaki, S., R. Armitage, M. Ahdieh, L. Park, and D. Cosman. 1996. Interleukin-15 up-regulates interleukin-2 receptor α chain but down-regulates its own high-affinity binding sites on human T and B cells. Eur. J. Immunol. 26:1235.